HKD 0.17
(27.48%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 99.22 Million HKD | -22.73% |
2022 | 128.42 Million HKD | -60.93% |
2021 | 328.72 Million HKD | 5.94% |
2020 | 310.3 Million HKD | 22.96% |
2019 | 252.36 Million HKD | 39.7% |
2018 | 180.63 Million HKD | -10.97% |
2017 | 202.9 Million HKD | -13.9% |
2016 | 235.65 Million HKD | -2.3% |
2015 | 241.19 Million HKD | 9.36% |
2014 | 220.55 Million HKD | 33.53% |
2013 | 165.16 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 99.22 Million HKD | -22.73% |
2023 Q2 | 108.29 Million CNY | -12.51% |
2023 Q1 | 123.78 Million CNY | -3.61% |
2023 Q4 | 112.64 Million CNY | 37.16% |
2023 Q3 | 82.12 Million CNY | -24.16% |
2022 FY | 128.42 Million HKD | -60.93% |
2022 Q4 | 128.42 Million HKD | -9.36% |
2022 Q3 | 141.69 Million HKD | -47.06% |
2022 Q2 | 267.62 Million HKD | 0.88% |
2022 Q1 | 265.27 Million HKD | -19.3% |
2021 Q4 | 328.72 Million HKD | -9.88% |
2021 Q3 | 364.76 Million HKD | 30.55% |
2021 Q1 | 330.63 Million HKD | 6.55% |
2021 FY | 328.72 Million HKD | 5.94% |
2021 Q2 | 279.41 Million CNY | -15.49% |
2020 Q3 | 352.73 Million HKD | 46.63% |
2020 FY | 310.3 Million HKD | 22.96% |
2020 Q4 | 310.3 Million CNY | -12.03% |
2020 Q1 | 262.2 Million HKD | 3.9% |
2020 Q2 | 240.55 Million HKD | -8.25% |
2019 Q2 | 229.07 Million HKD | -14.12% |
2019 FY | 252.36 Million HKD | 39.7% |
2019 Q4 | 252.36 Million HKD | -8.48% |
2019 Q3 | 275.73 Million HKD | 20.37% |
2019 Q1 | 266.74 Million HKD | 47.67% |
2018 Q2 | 184.49 Million HKD | -19.57% |
2018 Q3 | 204.63 Million HKD | 10.92% |
2018 Q1 | 229.37 Million HKD | 13.05% |
2018 FY | 180.63 Million HKD | -10.97% |
2018 Q4 | 180.63 Million HKD | -11.73% |
2017 FY | 202.9 Million HKD | -13.9% |
2017 Q1 | 181.98 Million HKD | -22.77% |
2017 Q2 | 162.57 Million HKD | -10.66% |
2017 Q3 | 236.75 Million HKD | 45.63% |
2017 Q4 | 202.9 Million HKD | -14.3% |
2016 FY | 235.65 Million HKD | -2.3% |
2016 Q2 | 232.83 Million HKD | 0.0% |
2016 Q3 | 272.45 Million HKD | 17.02% |
2016 Q4 | 235.65 Million HKD | -13.51% |
2016 Q1 | - HKD | 0.0% |
2015 FY | 241.19 Million HKD | 9.36% |
2014 FY | 220.55 Million HKD | 33.53% |
2013 FY | 165.16 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Starlite Holdings Limited | 266.35 Million HKD | 62.746% |
Litu Holdings Limited | 537.22 Million HKD | 81.529% |
Touyun Biotech Group Limited | 586.26 Million HKD | 83.075% |
Huaxi Holdings Company Limited | 173.29 Million HKD | 42.741% |